Australian Chemicals Stock News

Why EQ Resources is back in focus after a boardroom challenge EQ Resources (ASX:EQR) has drawn fresh attention after shareholder advocate Stephen Mayne nominated himself for the board. The company is urging investors to vote against his candidacy at the 16 March 2026 AGM. See our latest analysis for EQ Resources. The governance tussle comes after a sharp shift in trading sentiment, with a 1 day share price return of negative 12.77%, following a 30 day share price return of 95.24% and a 1 year...

Resimac Group Limited ( ASX:RMC ) shareholders should be happy to see the share price up 11% in the last week. But over...

We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly...

Insiders who acquired AU$638.6k worth of Alliance Aviation Services Limited's ( ASX:AQZ ) stock at an average price of...

Temple & Webster Group (ASX:TPW) has put fresh numbers on the table for H1 2026, with revenue of A$375.9 million, basic EPS of A$0.0481 and net income of A$5.8 million. This gives investors a clearer read on how the business is tracking through the current year. The company has seen revenue move from A$313.7 million and EPS of A$0.0757 in H1 2025 to A$287.0 million and EPS of A$0.0195 in H2 2025, then on to the latest A$375.9 million and EPS of A$0.0481. This sets up a story where top line...

Alkane Resources (ASX:ALK) has put up a punchy Q2 2026 scorecard, with revenue of A$256.7 million and Basic EPS of A$0.0496, backed by trailing twelve month revenue of A$544.8 million and EPS of A$0.0929 that reflect a very large uplift in earnings over the past year. The company has seen revenue climb from A$59.2 million in Q2 2025 to A$256.7 million in Q2 2026, while quarterly EPS moved from A$0.0032 to A$0.0496. This sets up a story where expanding earnings and a higher net profit margin...

Bioxyne Limited ( ASX:BXN ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...

The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to more...

ReadyTech Holdings Limited ( ASX:RDY ) shares have had a horrible month, losing 26% after a relatively good period...

Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying...

Unfortunately for some shareholders, the Life360, Inc. ( ASX:360 ) share price has dived 27% in the last thirty days...

The Star Entertainment Group Limited ( ASX:SGR ) shares have retraced a considerable 26% in the last month, reversing a...

When close to half the companies in Australia have price-to-earnings ratios (or "P/E's") above 22x, you may consider...

WAM Strategic Value Limited ( ASX:WAR ) will pay a dividend of A$0.0325 on the 29th of May. The dividend yield will be...

Civmec (ASX:CVL) has laid out a fresh set of H1 2026 numbers, with the latest half showing total revenue of A$307.7 million and basic EPS of A$0.03 alongside net income of A$16.0 million. Over recent halves the company has seen revenue move from A$541.1 million and EPS of A$0.06 in H2 2024 to A$502.9 million and EPS of A$0.05 in H1 2025. This sets the backdrop for today’s update and the current share price of A$1.56, and investors are now weighing those headline figures against slightly...

Cochlear (ASX:COH) has reported its H1 2026 results with trailing twelve month revenue of A$2.3b and basic EPS of A$5.28, giving investors a clear read on both top line scale and earnings power. The company has seen half year revenue move from A$1,137.1 million in H2 2024 to A$1,171.8 million in H1 2025 and A$1,171.3 million in H2 2025, while basic EPS shifted from A$2.53 to A$3.13 and then A$2.81 over the same periods. This sets the backdrop for a margin story that investors will parse...

Nick Scali (ASX:NCK) has released its H1 2026 scorecard, with investors already eyeing how the latest numbers fit into the broader trend in revenue and EPS. The company has seen half year revenue move from A$241.6 million in H2 2024 to A$251.1 million in H1 2025 and then A$244.2 million in H2 2025, while basic EPS shifted from A$0.457 to A$0.351 and then A$0.324 over the same periods. This gives investors a clear view of how recent trading has flowed through to the bottom line. With net...

Boab Metals (ASX:BML) has moved into focus after securing final works approvals for full construction at its Sorby Hills silver, lead and zinc project, marking a key step toward potential future production. See our latest analysis for Boab Metals. Those approvals and recent capital moves, including a A$60m follow on equity offering at A$0.40 and new director shares tied to Sorby Hills permits, come after strong momentum. The company has recorded a 90 day share price return of 52.38% and a...

In the past quarter, James Hardie Industries plc reported third-quarter 2025 sales of US$1,239.8 million, up from US$953.3 million a year earlier, while net income fell to US$68.7 million from US$141.7 million and basic earnings per share from continuing operations declined to US$0.12 from US$0.33. Despite the weaker headline profit, the company exceeded analyst expectations for adjusted earnings and revenue, highlighting strong sales growth supported by the early benefits of its AZEK...

ANZ Group Holdings (ASX:ANZ) is back in focus after revealing first quarter costs came in lower than analysts had expected, a surprise that has sharpened attention on the bank’s efficiency and profit potential. See our latest analysis for ANZ Group Holdings. The cost surprise has arrived on top of strong recent momentum, with ANZ’s 7 day share price return of 10.48% and 30 day share price return of 12.40% adding to a 1 year total shareholder return of 37.44%. This suggests sentiment has been...

MFF Capital Investments (ASX:MFF) has released its H1 2026 scorecard, with recent half-year figures showing H2 2025 revenue of A$68.5 million and basic EPS of A$0.09, alongside H1 2025 revenue of A$562.9 million and basic EPS of A$0.66. These are set against H2 2024 revenue of A$449.6 million and basic EPS of A$0.52. The company has also reported trailing 12‑month revenue of A$631.4 million with basic EPS of A$0.74 in H2 2025 and A$1.18 on A$1.0 billion of revenue in H1 2025, giving investors...

Insurance Australia Group (ASX:IAG) has put up another set of solid headline numbers for H1 2026, with trailing twelve month revenue of about A$17.4b and basic EPS of A$0.57 coming off net income of A$1,359m, while the latest reported half in 2025 delivered revenue of A$8.7b and EPS of A$0.25 on net income of A$581m. Over the past few reported halves the company has seen revenue move from A$8.1b in H2 2024 to A$8.7b in H1 2025 and A$8.7b in H2 2025, alongside EPS shifting from A$0.21 to...

Oneview Healthcare (ASX:ONE) has put fresh numbers on the table for FY 2025, reporting first half revenue of €6.3 million and a basic EPS loss of €0.01. Trailing twelve month revenue stands at €11.6 million with a basic EPS loss of €0.016452. Over recent periods the company’s revenue has moved from €4.7 million in the first half of 2024 to €5.2 million in the second half of 2024 and then to €6.3 million in the first half of 2025. Across the same periods, half year basic EPS figures have...

CAR Group (ASX:CAR) is back in focus after its latest half year earnings, where revenue reached A$625.79 million and net profit came in at A$143.34 million, alongside a higher interim dividend. See our latest analysis for CAR Group. Despite the solid half year update and higher dividend, the share price has had a tougher run, with a 30 day share price return of a 17.67% decline and a year to date share price return of an 18.79% decline. The 1 year total shareholder return of a 32.67% decline...